Jefferson Lab director named to 2024 Hampton Roads Power List
Jefferson Lab Director Stuart Henderson has been named to the Hampton Roads Power List- Top 25 compiled by Inside Business
2024-05-21
(Press-News.org) NEWPORT NEWS, VA – Stuart Henderson, director of the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility, has been named to the Hampton Roads Power List by Inside Business. The list recognizes the major players in Hampton Roads’ economy. According to Inside Business, the 2024 list considered milestones and current events, and it features “the talk of Hampton Roads and the change that’s coming.”
“I am honored to be included in this list of people who are moving Hampton Roads toward an ever brighter future,” said Jefferson Lab Director Stuart Henderson.
While in the past, Jefferson Lab’s mission was singularly focused on basic research, that mission is now beginning to expand. And with that expansion, the lab is poised to unleash bigger impacts for the region and nation.
Jefferson Lab has long worked to manage and mine the torrent of data it creates in its exploration of the fundamental building blocks of matter in nuclear physics experiments. It’s 1,900 affiliated researchers from around the world bore into those mountains of data for the nuggets that will reveal clues of the smallest particles and universal forces that are at work inside the atom.
Now, the lab will begin applying that expertise toward a broad range of DOE research topics with data challenges nationwide. With the announcement that Jefferson Lab will lead the development of and serve as a hub for the $300-500 million High Performance Data Facility (HPDF), the lab is poised to push data science and computing to the next level.
“Jefferson Lab staff was honored to be tapped by the DOE’s Advanced Scientific Computing Research program to lead this important project, and we are already working with our partners at Lawrence Berkeley National Laboratory to bring it to fruition,” said Jefferson Lab Director Stuart Henderson. “And we are beginning the initial work of designing a new facility that will house the HPDF hub at Jefferson Lab.”
The power list includes 80 people that the publication has selected as the top movers and shakers in the Hampton Roads region, with 25 top list makers shown by type of influence or power and 55 others who are making current, major contributions to the region’s economic strength and future.
The full list can be found on the Inside Business website, and Henderson’s listing is available here: https://www.dailypress.com/2024/05/13/inside-business-power-list-2024-features-the-talk-of-hampton-roads-and-the-change-thats-coming/
Further Reading
Inside Business’ Power List 2024 features the talk of Hampton Roads and the change that’s coming
-end-
Jefferson Science Associates, LLC, manages and operates the Thomas Jefferson National Accelerator Facility, or Jefferson Lab, for the U.S. Department of Energy's Office of Science. JSA is a wholly owned subsidiary of the Southeastern Universities Research Association, Inc. (SURA).
DOE’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-05-21
Irvine, Calif., May 21, 2024 — In a study published in Nature Materials, scientists from the University of California, Irvine describe a new method to make very thin crystals of the element bismuth – a process that may aid the manufacturing of cheap flexible electronics an everyday reality.
“Bismuth has fascinated scientists for over a hundred years due to its low melting point and unique electronic properties,” said Javier Sanchez-Yamagishi, assistant professor of physics & astronomy at UC Irvine and a co-author of the study. “We developed a new method to make very thin crystals ...
2024-05-21
CLEVELAND - When it comes to skin cancer, most people think of warnings about sunburn and tanning beds. Thoughts of “cancer genes” or inherited risks are reserved for diseases like breast cancer or colon cancer. A new study challenges this status quo by showing that genetics play a larger role in melanoma risk than recognized.
Physicians rarely order genetic screens to assess risk factors for patients with a family history of melanoma because, according to the previous, limited studies, only 2-2.5% of all cases are genetic. For the same reason, insurance companies rarely cover these tests outside of the most extreme ...
2024-05-21
Two Promising UCF Researchers Earn 2024 NSF CAREER Awards
Early-career professors Fan Yao and Li Fang are receiving significant research funding to continue catalyzing their work as part of an annual NSF grant program.
By Eddy Duryea ’13
ORLANDO, May 21, 2024 – UCF assistant professors Li Fang and Fan Yao have been named 2024 U.S. National Science Foundation (NSF) Faculty Early Career Development program (CAREER) award winners. The recipients were awarded funding through five years for their submitted projects.
Fang, who is an assistant professor in UCF’s Department of Physics within the College of Sciences, is using the ...
2024-05-21
Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to more weight lost in just a year, a new University of Michigan study finds.
Primary care clinicians commonly struggle to help patients develop an individualized weight-management treatment plan during short clinic visits. Previous U-M research showed that most primary care patients with ...
2024-05-21
[BOSTON, MAY 21, 2024] – Stuart Orkin, MD, a researcher at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School, has been honored with The Shaw Prize in Life Science & Medicine for his pioneering work discovering the genetic and molecular mechanisms underlying the switch from fetal to adult hemoglobin. Dr. Orkin shares the prize with Swee Lay Thein, PhD, Senior Investigator and Chief of the Sickle Cell Branch of National Heart, ...
2024-05-21
LA JOLLA, CA—Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place? Now, scientists at Scripps Research and the Albert Einstein College of Medicine have designed drug-like molecules to do just that, by thwarting the first stage of influenza infection.
The drug-like inhibitors block the virus from entering the body’s respiratory cells—specifically, they target hemagglutinin, a protein on the surface of type A influenza viruses. The findings, published in the Proceedings of the National Academy of Sciences ...
2024-05-21
In a new review paper, Carlo Maley and Arizona State University colleagues describe cell-in-cell phenomena in which one cell engulfs and sometimes consumes another. The study shows that cases of this behavior, including cell cannibalism, are widespread across the tree of life.
The findings challenge the common perception that cell-in-cell events are largely restricted to cancer cells. Rather, these events appear to be common across diverse organisms, from single-celled amoebas to complex multicellular animals.
The widespread occurrence of such interactions in non-cancer cells suggests that these events are not inherently "selfish" or "cancerous" ...
2024-05-21
“Despite the potential advantages of utilizing UV-C radiation for deactivating pathogens such as SARS-CoV-2, the prevailing conclusion remains that UV-C radiation poses concurrent risks to human health.”
BUFFALO, NY- May 21, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 9, entitled, “Germicidal lamps using UV-C radiation may pose health safety issues: a biomolecular analysis of their effects on apoptosis and senescence.”
The battle against the COVID-19 pandemic has spurred a heightened state of vigilance in global healthcare, ...
2024-05-21
“Our research findings suggest that miR-377 could potentially serve as a valuable therapeutic strategy for the treatment of prostate cancer (PCa).”
BUFFALO, NY- May 21, 2024 – A new research paper was published in Genes & Cancer on May 16, 2024, entitled, “Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.”
The MYC gene is a regulatory and proto-oncogenic gene that is overexpressed in the majority of prostate cancers (PCa). Numerous studies have indicated that aberrant expression of microRNAs is involved in the ...
2024-05-21
In a groundbreaking study, scientists have explored a novel approach to detect electrothermal ureteral injuries, a common complication during pelvic surgery. The ureters, delicate tubes that transport urine from the kidneys to the bladder, are particularly vulnerable due to their proximity to other anatomical structures. Unfortunately, current detection methods often fall short in promptly identifying subtle thermal injuries, which can take days or even weeks to manifest.
Enter optical coherence tomography ...
LAST 30 PRESS RELEASES:
[Press-News.org] Jefferson Lab director named to 2024 Hampton Roads Power List
Jefferson Lab Director Stuart Henderson has been named to the Hampton Roads Power List- Top 25 compiled by Inside Business
